NIH Reporter #1F32HL178335-01

NHLBI Solicitation: Research on Biomarkers of Ischemic Risk in Sickle Cell Disease

The National Heart, Lung, and Blood Institute (NHLBI) is seeking research services to advance stroke prevention in adults with sickle cell disease. - Government Buyer: - National Heart, Lung, and Blood Institute (NHLBI) - OEMs and Vendors: - No specific OEMs or commercial vendors are named - Collaboration with Vanderbilt University Medical Center is required - Products/Services Requested: - Research service: 'Biomarkers of ischemic risk in adults with sickle cell disease' - Focus on investigating cerebral oxygen utilization using non-invasive imaging techniques - No part numbers or quantities specified - Unique/Notable Requirements: - Emphasis on non-invasive imaging for biomarker development - Research must target stroke prevention in adults with sickle cell disease - Collaboration with an academic medical center (Vanderbilt) is integral to the project

Description

This project aims to investigate cerebral oxygen utilization in adults with sickle cell disease using non-invasive imaging techniques to develop biomarkers for stroke prevention. The research is funded by the National Heart Lung and Blood Institute (NHLBI) and involves collaboration with Vanderbilt University Medical Center. The project duration is from December 1, 2025, to November 30, 2027, with a total award amount of $78,040. The solicitation is open for responses until May 27, 2024.

View original listing